Current Perspective of Antiviral Strategies against COVID-19.

Please use this identifier to cite or link to this item: https://doi.org/10.1021/acsinfecdis.0c00236

Title:	Current Perspective of Antiviral Strategies against COVID-19.
Authors:	Ahidjo, Bintou Ahmadou Loe, Marcus Ng, Yan Ling Mok, Chee Keng Chu, Justin Jang Hann
Issue Date:	2-Jun-2020
Publisher:	American Chemical Society (ACS)
Citation:	Ahidjo, Bintou Ahmadou, Loe, Marcus, Ng, Yan Ling, Mok, Chee Keng, Chu, Justin Jang Hann (2020-06-02). Current Perspective of Antiviral Strategies against COVID-19.. ACS Infect Dis. ScholarBank@NUS Repository. https://doi.org/10.1021/acsinfecdis.0c00236
Abstract:	COVID-19 was declared a pandemic by the World Health Organisation on March 11, 2020. This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe and unprecedented social and economic disruptions globally. Since the discovery of COVID-19 in December 2019, numerous antivirals have been tested for efficacy against SARS-CoV-2 in vitro and also clinically in order to treat this disease. This review article discusses the main antiviral strategies currently employed and summarizes reported in vitro and in vivo efficacies of key antiviral compounds in use.
Source Title:	ACS Infect Dis
URI:	https://scholarbank.nus.edu.sg/handle/10635/173619
ISSN:	23738227
DOI:	10.1021/acsinfecdis.0c00236
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
58.pdf	Accepted version	849.78 kB	Adobe PDF	OPEN	Post-print	View/Download

Check